Pharmabiz27m
BerGenBio announces safety data from phase 1b portion of BGBC016 study in first-line NSCLC
BerGenBio announces safety data from phase 1b portion of BGBC016 study in first-line NSCLC: Bergen, Norway Tuesday, October 8, 2024, 15:00 Hrs [IST] BerGenBio ASA, a clinical-stag ...
Pharmabiz1h
Dräger India gives a boost to pre-natal care with its new TN300 Open Warmer BabyRoo
Dräger India gives a boost to pre-natal care with its new TN300 Open Warmer BabyRoo: Our Bureau, Bengaluru Tuesday, October 8, 2024, 13:50 Hrs [IST] Dräger India has launched Ba ...
Pharmabiz1h
OneSource, a multimodal global specialty pharma CDMO of Strides Group unveils new brand identity at CPHI, Milan
OneSource, a multimodal global specialty pharma CDMO of Strides Group unveils new brand identity at CPHI, Milan: Our Bureau, Bengaluru Tuesday, October 8, 2024, 13:30 Hrs [IST] On ...
Pharmabiz1h
AstraZeneca inks license agreement with CSPC Pharma to develop an early stage, novel small molecule Lipoprotein (a)
AstraZeneca inks license agreement with CSPC Pharma to develop an early stage, novel small molecule Lipoprotein (a) ...
Pharmabiz2h
GE HealthCare completes phase I clinical development programme for a first-of-its-kind manganese-based macrocyclic MRI contrast agent
Chalfont St Giles, England Tuesday, October 8, 2024, 13:00 Hrs [IST] ...
Pharmabiz1h
Gleneagles Hospitals, Parel, Mumbai appoints Dr Bipin Chevale as CEO
Gleneagles Hospitals, Parel, Mumbai appoints Dr Bipin Chevale as CEO: Our Bureau, Mumbai Tuesday, October 8, 2024, 13:40 Hrs [IST] Dr Bipin Chevale has been named the chief execut ...
Pharmabiz4h
Hansa Biopharma announces positive results from NICE-01 trial of next generation IgG-cleaving molecule, HNSA-5487
Hansa Biopharma announces positive results from NICE-01 trial of next generation IgG-cleaving molecule, HNSA-5487: Lund, Sweden Tuesday, October 8, 2024, 11:00 Hrs [IST] Hansa Bio ...
Pharmabiz3h
Lesaffre strengthens research, development & innovation with the acquisition of French start-up Altar
Lesaffre strengthens research, development & innovation with the acquisition of French start-up Altar: Marcq-en-Barœul, France Tuesday, October 8, 2024, 12:00 Hrs [IST] Lesaffre, ...
Pharmabiz5h
MEDICAL JAPAN 2024 to be held in Makuhari Messe, Japan from October 9 to 11
MEDICAL JAPAN 2024 returns to Makuhari Messe, Japan from October 9 to 11 and will be providing exhibitors and visitors access to the Japanese and Asian markets to expand their business footprint. The ...
Pharmabiz6h
AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint
AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint: Cambridge, UK Tuesday, October 8, 2024, 09:00 H ...
Pharmabiz7h
IPEC’s GDP guideline to bring Indian suppliers in line with uniform global practices
IPEC’s GDP guideline to bring Indian suppliers in line with uniform global practices: Nandita Vijayasimha, Bengaluru Tuesday, October 8, 2024, 08:00 Hrs [IST] The International ...
Pharmabiz7h
DTAB recommends inclusion of QR Codes for anti-cancer drugs
In an effort to fight counterfeiting of costly cancer medicines which put the lives of patients at risk, the Drugs Technical Advisory Board (DTAB), the body that advises the Central and state ...